In-Vitro Toxicology Testing Market worth $17,227 Million by 2018 http://www.marketsandmarkets.com/Market-Reports/in-vitro-toxicology-testingmarket-209577065.html
The “In-Vitro Toxicology/ Toxicity Testing Market by Industry (Diagnostic, Pharmaceutical, Cosmetics, Chemical), Technology (Cell Culture, HTS, Omics), Applications (Systemic, Dermal, Ocular),Method (Cellular Assay, Ex vivo, In Silico) - Global Forecast to 2018” provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the global In-vitro toxicology testing market along with the estimates and forecasts of the revenue and share analysis. Browse 67 market data tables, 25 figures spread through 246 pages and in-depth TOC on “In-Vitro Toxicology/ Toxicity Testing Market”. http://www.marketsandmarkets.com/Market-Reports/in-vitro-toxicology-testing-market209577065.html
Early buyers will receive 10% customization on reports.
The global in-vitro toxicology testing market is estimated to reach $17,227 million by 2018 at a CAGR of 13.5% during the forecast period (2013â€“2018). The market will witness a double-digit growth attributed to the increasing acceptance of in vitro methods over in vivo ones. Government support to stop animal testing, new and promising technologies, and advancement in new approaches are significant factors propelling the market in the forecast period. On the other hand, predictive ability of in vitro testing and limitation of the methods to replicate true in vivo conditions are the factors that hinder the market. The government programs such as the TOX 21 initiated by the U.S. government and growing number of drug discoveries and innovations globally represent an opportunity for the growth of the market. Download Free PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=209577065
Cell culture technology accounted for the largest share of the global in-vitro toxicology testing market in 2013. This segment will also witness the fastest growth from 2013 to 2018. Cell culture technology is gaining acceptance as the necessary tool to determine toxicity in earlier stages of drug development. With the introduction of 3D models the cell based assays will further observe strong growth.
The key players in the market are Agilent Technologies (U.S.), Alere, Inc. (U.S.), Bio-Rad (U.S.), BioReliance (Sigma Aldrich) (U.S.), Catalent Pharma Solutions (U.S.), Charles River Laboratories (U.S.), Covance (U.S.), Cyprotex (U.K.), Eurofins Scientific, Inc (U.S.), GE Healthcare (U.K.), Life Technologies Corporation (Thermo Fisher Scientific) (U.S.), and Quest Diagnostics (U.S.). Inquiry Before Buying: http://www.marketsandmarkets.com/Enquiry_Before_Buying.asp?id=209577065
About MarketsandMarkets MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.
MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals, including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT. We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.
Contact Us Mr. Rohan North - Dominion Plaza, 17304 Preston Road, Suite 800, Dallas, TX 75252 Tel: +1-888-6006-441 Email: email@example.com MarketsandMarkets Blog http://www.marketsandmarkets.com http://twitter.com/marketsmarkets http://www.linkedin.com/company/marketsandmarkets